, along with 7 known compounds 2 -8 were isolated from the leaves of Crypsinus trilobus (Houtt.) Copel. (Polypodiaceae) for the first time. Their structures were elucidated on the basis of HR-ESI-MS, 1D and 2D NMR spectra.
Crypsinus is a genus belonging to the family Polypodiaceae, distributed in China and Southeast Asia [1] . Several species are used in folk medicine to treat some diseases such as fever, rheumatism, edema, skin diseases [2] but there have not been any reports on chemical and biological properties for Crypsinus trilobus (Houtt.) Copel., distributed mainly in forest areas of Central Vietnam. In Vietnamese traditional medicine, the species is used to treat arthritis as decoction or medicinal wine [3] . To date, no studies on chemical constituents as well as biological activities of the plant have been reported. Therefore, a basic research on the plant is necessary to clarify its usage in folk medicine. In present paper, we report the isolation and structural identification of a new flavonol glucoside, crypsinoside A (1), together with 7 known compounds, kaempferol 3-O-(3ʺ,6ʺ-diacetyl)-β-D-glucopyranoside (2), (7S,8R,8ʹR)-5ʹ-methoxy isolariciresinol (3), protocatechuic acid (4), stigmastane-3β,5α,6β-triol (5), β-sitosterol (6), daucosterol (7) and β-sitosterol 3-O-β-D-glucopyranosyl palmitate) (8) [4] [5] [6] [7] [8] . All seven compounds (2 -8) were isolated from the leaves of C. trilobus for the first time.
Compound 1 was obtained as a yellow amorphous powder. The molecular formula of 1 was determined to be C 34 H 30 O 15 based on HR-ESI-MS with [M-H] -ion peak at m/z 677.1534 (calcd 677.1507). The 1 H NMR spectra of 1 showed ten aromatic proton signals. Six of them were assigned to a kaempferol skeleton [9] at  of methyl groups at  H 2.10 and 2.20 recommended the appearance of two acetyl groups ( Figure 1 ). Compatibly with above evidence, the 13 C NMR of 1 revealed 34 carbon signals responsible for a kaempferol skeleton (15 carbon atoms), a coumaroyl fragment (9 carbon atoms), a glucopyranosyl moiety (6 carbon atoms) and two acetyl groups (4 carbon atoms) ( Figure 1 ). These predictions are completely based on the data obtained from the HSQC, HMBC and COSY spectra. The HMBC correlation from anomeric proton ( H 5.56) to C-3 ( C 134.37) indicated the sugar moiety was at C-3 of kaempferol aglycone, while the HMBC correlation from proton H-6ʺ of glucose ( H 4.10) to the carbonyl group C-9‴ of coumaroyl moiety ( C 168.37) suggested that coumaroyl moiety was attached at C-6ʺ of sugar. In addition, two acetyl groups were at C-2ʺ and C-4ʺ of glucopyranose, which was observed on the basis of HMBC cross-peaks from H-2ʺ ( H 5.05) to C=O ( H 172.04) and from H-4ʺ ( H 4.90) to C=O ( H 171.75), respectively. As a result, compound 1, a new flavonol glucoside, was identified as kaempferol 3-O-
which was named as crypsinoside A. The similar compound to 1, 
Extraction and Isolation:
The dried leaves of Crypsinus trilobus (2.5 kg) were powdered and extracted with methanol at 50 o C (3 times x 2 hours per time) on heated ultrasonic machine to give 140.0 g residue, which was then suspended in water and successively partitioned with n-hexane and ethyl acetate (EtOAc). The EtOAc fraction (52.0 g) was separated by silica gel CC using the gradient of n-hexane-EtOAc (100:0, 75:25, 50:50, 25:75, 0:100, v:v) to obtain 5 fractions (E1→E5). The fraction E1 (12.0 g) was chromatographed on silica gel column and eluted with n-hexaneEtOAc (10:1) to give five sub-fractions (E1.1 to E1.5). The subfraction E1.3 (0.90 g) was firstly separated by silica gel column and eluted with n-hexane-EtOAc (8:1) and then recrystallized in nhexane-acetone (4:1) to yield compound 6 (15 mg). The fraction E1.5 (1.20 g) was subjected to silica gel column and eluted with nhexane-EtOAc (12:1) to give four sub-fractions (E1.5.1 to E1.5.4). Compound 8 (12 mg) was obtained from the sub-fraction E1.5.2. The fraction E2 (14.0 g) was separated on silica gel column using nhexane-acetone (8:1) to obtain five sub-fractions (E2.1 to E2.5). The sub-fraction E2.2 (1.0 g) was passed through on silica gel column using chloroform-methanol (25:1) to give 4 sub-fractions (E2.2.1 to E2.2.4). Compound 5 (6 mg) was isolated from the subfraction E2.2.2 by using YMC RP-18 column with methanol-water (3:1). The sub-fraction E2.2.4 was firstly chromatographed on silica gel column eluting with chloroform-methanol (30:1) and further purified on silica gel column eluting with dichloromethanemethanol (10:1) to obtain compound 7 (17 mg). The fraction E3 (10.5 g) was subjected to silica gel column and eluted with EtOAcmethanol (25:1) to give six sub-fractions (E3.1 to E3.6). The subfraction E3.2 (1.1 g) was chromatographed on silica gel column and eluted with chloroform-methanol (15:1) to give three sub-fractions (E3.2.1 to E3.2.3). The sub-fraction E3.2.3 was separated on silica gel column using chloroform-methanol-water (10:1:0,1) and then purified on YMC RP-18 column eluting with methanol-water (3:2) to give compound 1 (5 mg). Compound 2 (7 mg) was purified from the sub-fraction E3.2.2 by using an YMC RP-18 column with methanol-water (2:1). The fraction E4 (6.5 g) was passed through on silica gel column using EtOAc-methanol (25:1) to obtain four sub-fractions (E4.1 to E4.4). The sub-fraction E4.3 was continuously chromatographed on silica gel column and eluted with chloroform-methanol (15:1) and then purified on an YMC RP-18 column eluting with methanol-water (2:1) to give compound 3 (4 mg). The fraction E5 (9.0 g) was separated on a silica gel column using chloroform-methanol (15:1) to give three sub-fractions (E5.1 to E5.3). Compound 4 (8 mg) was achieved from the sub-fraction E5.2 by using a silica gel column eluted with chloroform-methanol (8:1). 
